CClinicalTrials.gg
Not yet recruitingNCT07661654Updated Jun 22, 2026

HBM-Based Education for Retinopathy of Prematurity Screening in Parents of Premature Infants

An interventional study of HBM-Based Video Education and HBM-Based Audio Education in Retinopathy of Prematurity (ROP), sponsored by Aga Khan University. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-22.

Sponsored by Aga Khan University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
99
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this clinical trial is to learn whether Health Belief Model (HBM)-based educational interventions can improve knowledge and practices related to Retinopathy of Prematurity (ROP) screening among parents of premature infants attending ROP clinics in Karachi, Pakistan. The main questions it aims to answer are:

  • Do HBM-based educational interventions improve parents' knowledge about Retinopathy of Prematurity screening?
  • Do HBM-based educational interventions improve parents' screening-related practices and follow-up for Retinopathy of Prematurity?

Researchers will compare different educational approaches, including video-based education, audio-based education, and standard educational material, to see which method is more effective in improving parental understanding and practices regarding ROP screening.

Participants will:

  • Complete a questionnaire assessing their knowledge and practices related to Retinopathy of Prematurity screening at baseline
  • Receive one of the following educational approaches: video message plus counselling and pamphlet, audio message plus counselling and pamphlet, or counselling and pamphlet only
  • Attend a follow-up visit approximately 2 weeks after the initial visit
  • Complete a follow-up questionnaire to assess changes in knowledge and practices related to Retinopathy of Prematurity screening
Read the detailed description

Retinopathy of Prematurity (ROP) is a retinal vascular disorder affecting premature infants and remains a leading preventable cause of childhood blindness worldwide. Premature infants, particularly those born before 37 weeks of gestation and with low birth weight, are at increased risk of developing ROP. Timely screening and follow-up are critical to prevent severe visual impairment; however, delayed presentation and poor adherence to follow-up appointments remain important barriers to effective management, especially in low- and middle-income countries.

Parental awareness and engagement are essential for ensuring timely screening and treatment. Conventional parental education methods, such as routine verbal communication and printed informational materials, may be limited by parental stress, health literacy, language barriers, and inconsistent access to healthcare information. Consequently, there is a need for evidence-based educational strategies that improve parental understanding and encourage timely health-seeking behavior.

The Health Belief Model (HBM) provides a theoretical framework for understanding and promoting preventive health behaviors by addressing perceived susceptibility, perceived severity, perceived benefits, perceived barriers, self-efficacy, and cues to action. Applying this framework to parent education may improve awareness regarding the risks of untreated ROP and the importance of screening and follow-up.

This randomized controlled trial will evaluate the effectiveness of Health Belief Model-based educational interventions for parents of premature infants attending Retinopathy of Prematurity clinics at Aga Khan University Hospital, Karachi, Pakistan. The study compares multiple educational delivery methods integrated into routine clinical care to determine whether structured educational approaches can improve parental understanding and engagement in ROP screening.

Educational materials have been developed by the Department of Ophthalmology and Visual Sciences and are available in English and Urdu to improve accessibility and cultural appropriateness. Findings from this study are expected to inform strategies for strengthening parental education and improving neonatal ophthalmic care in resource-limited settings.

02

Conditions studied

  • Retinopathy of Prematurity (ROP)
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Mother or father of a premature infant attending Retinopathy of Prematurity (ROP) clinic
  • Parent aged 18 years or older
  • Parent of a premature infant who was admitted to the Neonatal Intensive Care Unit (NICU)
  • Able to understand English or Urdu
  • Willing and able to provide written informed consent

Exclusion criteria

Exclusion Criteria:

  • Parents with disability or cognitive impairment affecting participation
  • Uncooperative participants
  • Parents unwilling or unable to provide informed consent
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
99 participants (estimated)

Study arms

  • Experimental
    Video Message + Counselling + Pamphlet

    Participants will receive a Health Belief Model-based educational video regarding Retinopathy of Prematurity (ROP), along with counselling by an ophthalmologist and a user-friendly educational pamphlet in English or Urdu.

    Behavioral: HBM-Based Video Education

  • Experimental
    Audio Message + Counselling + Pamphlet

    Participants will receive a Health Belief Model-based educational audio message regarding Retinopathy of Prematurity (ROP), along with counselling by an ophthalmologist and a user-friendly educational pamphlet in English or Urdu.

    Behavioral: HBM-Based Audio Education

  • Active comparator
    Counselling + Pamphlet (Control)

    Participants will receive standard educational information through counselling by an ophthalmologist and a user-friendly educational pamphlet regarding Retinopathy of Prematurity (ROP).

    Behavioral: Standard Counselling and Pamphlet

Interventions

  • BehavioralHBM-Based Video Education

    Participants will receive a Health Belief Model-based educational video regarding Retinopathy of Prematurity (ROP), including information on disease development, risk factors, importance of timely screening, treatment options, and follow-up. Counselling by an ophthalmologist and a user-friendly pamphlet in English or Urdu will also be provided.

  • BehavioralHBM-Based Audio Education

    Participants will receive a Health Belief Model-based educational audio message regarding Retinopathy of Prematurity (ROP), including information on disease development, risk factors, importance of timely screening, treatment options, and follow-up. Counselling by an ophthalmologist and a user-friendly pamphlet in English or Urdu will also be provided.

  • BehavioralStandard Counselling and Pamphlet

    Participants will receive standard educational information through counselling by an ophthalmologist and a user-friendly pamphlet regarding Retinopathy of Prematurity (ROP). Educational materials will be provided in English or Urdu.

05

What researchers measure

Primary outcomes

  1. Change in Retinopathy of Prematurity Knowledge Score

    Knowledge regarding Retinopathy of Prematurity (ROP) will be assessed using a structured 10-item ROP Knowledge Questionnaire completed by parents. Items assess knowledge related to ROP risk factors, screening, treatment, and complications. Correct responses receive a score of 1 and incorrect or "I do not know" responses receive a score of 0. Total scores range from 0 to 10, with higher scores indicating better knowledge. Change in total score will be assessed by comparing baseline and follow-up questionnaire scores.

    Time frame: Baseline to follow-up visit (approximately 2 weeks after initial visit)

Secondary outcomes

  1. Change in HBM Perceptions Regarding ROP Screening

    Parental perceptions regarding Retinopathy of Prematurity (ROP) screening will be assessed using a structured Health Belief Model (HBM)-Based ROP Screening Questionnaire evaluating perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy. Questionnaire items are measured using a 5-point Likert scale ranging from 1 to 5, with higher scores indicating stronger agreement with positive health beliefs related to ROP screening. Change in questionnaire scores will be assessed between baseline and follow-up.

    Time frame: Baseline to follow-up visit (approximately 2 weeks after initial visit)

06

Study locations

No study locations are listed for this record.

07

References and documents

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared due to participant confidentiality considerations and institutional data protection policies. The study involves questionnaire-based data collected from parents of premature infants, and no formal data-sharing agreement or repository is planned as part of the approved study protocol.

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07661654
Lead sponsor
Aga Khan University
Collaborators
University of Alberta
Responsible party
Khadijah Abid (Sr. Instructor (Research), Aga Khan University Hospital, Pakistan) — Principal investigator
First posted
Jun 22, 2026
Start date
Jul 2026 (estimated)
Primary completion
Feb 2027 (estimated)
Completion
Apr 2027 (estimated)
Last update
Jun 22, 2026

Study contacts

Khadijah Abid
Contact
khadijah.abid@aku.edu
+92-021-34930051
Fariha Ali
Contact
ali.fariha@aku.edu
Khadijah Abid
principal investigator · Aga Khan University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion